Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd

<< Previous

Bullboard Posts

Next >>

Post by saintpeteron Sep 22, 2020 7:06pm

74 Views

Post# 31601510

market depth

V:VXL Depth by Order @15:59:34

Bid			Ask
Broker	Size	Price	Price	Size	Broker
79 CIBC	10,000	0.10	0.105	25,000	7 TD Sec
19 Desjardins	40,000	0.10	0.105	3,500	33 Canaccord
9 BMO Nesbitt	9,000	0.10	0.105	10,000	1 Anonymous
19 Desjardins	20,000	0.10	0.105	51,500	7 TD Sec
2 RBC	15,000	0.10	0.11	14,500	2 RBC
68 Leede	500	0.10	0.11	11,500	7 TD Sec
7 TD Sec	38,500	0.10	0.11	46,000	7 TD Sec
79 CIBC	17,400	0.10	0.11	19,000	85 Scotia
7 TD Sec	30,000	0.10	0.11	12,500	85 Scotia
2 RBC	1,000	0.10	0.11	10,000	9 BMO Nesbitt